Tumour-targeting nanoparticles loaded with a drug that makes cancer cells more vulnerable to chemotherapy's toxicity can be a new approach in the treatment of endometrial cancer -- that begins in the uterus, researchers suggest.Combining traditional chemotherapy with the relatively new cancer drug that attacks chemo-resistant tumour cells, the researchers packed both into tiny nanoparticles to create an extremely selective and lethal cancer treatment. The super-lethal nanoparticles reduced tumour growth and extended survival rates, a researcher said. "For the first time, we were able to combine two different tumour-targeting strategies and use them to defeat deadly Type II endometrial cancer.
"We believe this treatment could be used to fight other cancers, as well," said lead researcher. In mice with Type II endometrial cancer, the team combined two anti-cancer drugs: paclitaxel, a…
